Intracellular replication of fusobacteria requires new actin filament formation of epithelial cells - PubMed (original) (raw)
Intracellular replication of fusobacteria requires new actin filament formation of epithelial cells
Ulvi Kahraman Gursoy et al. APMIS. 2008 Dec.
Abstract
We examined survival and replication of fusobacteria inside epithelial cells. Subconfluent cultures of HaCaT keratinocytes were infected with five bacterial strains representing three Fusobacterium species: F. nucleatum, F. necrophorum, and F. mortiferum. Adhesion and invasion of the bacteria were assayed before and after antibiotic treatment that killed the adhered and extracellular bacteria. The number of live fusobacteria was examined by bacterial culturing after sonication of the epithelial cells. The role of host cell cytoskeleton functions was examined by treating the epithelial cells with cell function inhibitors. Number of viable epithelial cells was measured with the CellTiter96 kit. The tested Fusobacterium species adhered to and invaded the epithelial cells, and multiplied intracellularly for several hours. Thereafter, the intracellular number of bacteria rapidly declined. Concomitantly, viable fusobacteria were detected in the culture medium. Treatment of the infected epithelial cells with an actin formation inhibitor markedly reduced the number of living intracellular fusobacteria. Newly formed actin filaments were seen by confocal microscopy in the epithelial cells associated with the invaded bacteria. Fusobacteria infection did not reduce the number of viable epithelial cells in culture. Thus, fusobacteria are able to adhere to and invade epithelial cells, and survive under aerobic conditions. This property may enable them to survive in mucosa and participate in various disease processes of oral and pharyngeal tissues.
Similar articles
- Prevotella intermedia ATCC 25611 targets host cell lamellipodia in epithelial cell adhesion and invasion.
Gursoy UK, Könönen E, Uitto VJ. Gursoy UK, et al. Oral Microbiol Immunol. 2009 Aug;24(4):304-9. doi: 10.1111/j.1399-302X.2009.00510.x. Oral Microbiol Immunol. 2009. PMID: 19572892 - Stimulation of epithelial cell matrix metalloproteinase (MMP-2, -9, -13) and interleukin-8 secretion by fusobacteria.
Gursoy UK, Könönen E, Uitto VJ. Gursoy UK, et al. Oral Microbiol Immunol. 2008 Oct;23(5):432-4. doi: 10.1111/j.1399-302X.2008.00453.x. Oral Microbiol Immunol. 2008. PMID: 18793368 - Co-adhesion and biofilm formation by Fusobacterium nucleatum in response to growth pH.
Zilm PS, Rogers AH. Zilm PS, et al. Anaerobe. 2007 Jun-Aug;13(3-4):146-52. doi: 10.1016/j.anaerobe.2007.04.005. Epub 2007 Apr 25. Anaerobe. 2007. PMID: 17540586 - Fusobacteria: new taxonomy and related diseases.
Bennett KW, Eley A. Bennett KW, et al. J Med Microbiol. 1993 Oct;39(4):246-54. doi: 10.1099/00222615-39-4-246. J Med Microbiol. 1993. PMID: 8411084 Review. - Fusobacterial infections: an underestimated threat.
Roberts GL. Roberts GL. Br J Biomed Sci. 2000;57(2):156-62. Br J Biomed Sci. 2000. PMID: 10912293 Review.
Cited by
- Differential involvement of the canonical and noncanonical inflammasomes in the immune response against infection by the periodontal bacteria Porphyromonas gingivalis and Fusobacterium nucleatum.
De Andrade KQ, Almeida-da-Silva CLC, Ojcius DM, Coutinho-Silva R. De Andrade KQ, et al. Curr Res Microb Sci. 2021 Feb 23;2:100023. doi: 10.1016/j.crmicr.2021.100023. eCollection 2021 Dec. Curr Res Microb Sci. 2021. PMID: 34841314 Free PMC article. - Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer.
Tong Y, Lu G, Wang Z, Hao S, Zhang G, Sun H. Tong Y, et al. Front Immunol. 2023 May 3;14:1154818. doi: 10.3389/fimmu.2023.1154818. eCollection 2023. Front Immunol. 2023. PMID: 37207216 Free PMC article. - MicroRNA-31 induced by Fusobacterium nucleatum infection promotes colorectal cancer tumorigenesis.
Tang B, Lu X, Tong Y, Feng Y, Mao Y, Dun G, Li J, Xu Q, Tang J, Zhang T, Deng L, He X, Lan Y, Luo H, Zeng L, Xiang Y, Li Q, Zeng D, Mao X. Tang B, et al. iScience. 2023 Apr 26;26(5):106770. doi: 10.1016/j.isci.2023.106770. eCollection 2023 May 19. iScience. 2023. PMID: 37216106 Free PMC article. - Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy.
Alkharaan H, Lu L, Gabarrini G, Halimi A, Ateeb Z, Sobkowiak MJ, Davanian H, Fernández Moro C, Jansson L, Del Chiaro M, Özenci V, Sällberg Chen M. Alkharaan H, et al. Front Immunol. 2020 Aug 28;11:2003. doi: 10.3389/fimmu.2020.02003. eCollection 2020. Front Immunol. 2020. PMID: 32983143 Free PMC article. - Fusobacterium Species and Subspecies Differentially Affect the Composition and Architecture of Supra- and Subgingival Biofilms Models.
Thurnheer T, Karygianni L, Flury M, Belibasakis GN. Thurnheer T, et al. Front Microbiol. 2019 Jul 30;10:1716. doi: 10.3389/fmicb.2019.01716. eCollection 2019. Front Microbiol. 2019. PMID: 31417514 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources